AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

PROCESS FOR MANUFACTURE OF TELMISARTAN PATENT US2013137878 (A1)30 MAY 2013

 PATENTS  Comments Off on PROCESS FOR MANUFACTURE OF TELMISARTAN PATENT US2013137878 (A1)30 MAY 2013
Jun 012013
 

READ ALL AT

http://newdrugapprovals.wordpress.com/2013/06/01/process-for-manufacture-of-telmisartan-patent-us2013137878-a130-may-2013/

Share

GSK, Genmab announce positive results from Phase III study of Arzerra (ofatumumab)

 drugs  Comments Off on GSK, Genmab announce positive results from Phase III study of Arzerra (ofatumumab)
Jun 012013
 

may30,2013–GlaxoSmithKline (GSK) and Genmab (GEN) have announced positive results from Phase III study of Arzerra (ofatumumab) in combination with chlorambucil for the treatment of chronic lymphocytic leukaemia (CLL) patients.

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: